589 related articles for article (PubMed ID: 32983106)
1. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
2. T cells expressing multiple co-inhibitory molecules in acute malaria are not exhausted but exert a suppressive function in mice.
Brandi J; Lehmann C; Kaminski LC; Schulze Zur Wiesch J; Addo M; Ramharter M; Mackroth M; Jacobs T; Riehn M
Eur J Immunol; 2022 Feb; 52(2):312-327. PubMed ID: 34752634
[TBL] [Abstract][Full Text] [Related]
3. Differential expression pattern of co-inhibitory molecules on CD4
Abel A; Steeg C; Aminkiah F; Addai-Mensah O; Addo M; Gagliani N; Casar C; Yar DD; Owusu-Dabo E; Jacobs T; Mackroth MS
Sci Rep; 2018 Mar; 8(1):4789. PubMed ID: 29555909
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.
Schulte S; Heide J; Ackermann C; Peine S; Ramharter M; Mackroth MS; Woost R; Jacobs T; Schulze Zur Wiesch J
Clin Exp Immunol; 2022 Apr; 207(2):227-236. PubMed ID: 35020841
[TBL] [Abstract][Full Text] [Related]
5. Impaired Cytotoxic CD8
Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
mBio; 2020 Sep; 11(5):. PubMed ID: 32948688
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal SARS-CoV-2-specific CD8
Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Multiple Co-Inhibitory Molecules on Malaria-Induced CD8
Brandi J; Riehn M; Hadjilaou A; Jacobs T
Front Immunol; 2022; 13():878320. PubMed ID: 35874786
[TBL] [Abstract][Full Text] [Related]
8. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
Front Immunol; 2020; 11():576743. PubMed ID: 33519801
[TBL] [Abstract][Full Text] [Related]
9. Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
[TBL] [Abstract][Full Text] [Related]
10. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
11. Systemically comparing host immunity between survived and deceased COVID-19 patients.
Wang F; Hou H; Yao Y; Wu S; Huang M; Ran X; Zhou H; Liu Z; Sun Z
Cell Mol Immunol; 2020 Aug; 17(8):875-877. PubMed ID: 32541836
[No Abstract] [Full Text] [Related]
12. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
[TBL] [Abstract][Full Text] [Related]
13. Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
Hoffmann M; Pantazis N; Martin GE; Hickling S; Hurst J; Meyerowitz J; Willberg CB; Robinson N; Brown H; Fisher M; Kinloch S; Babiker A; Weber J; Nwokolo N; Fox J; Fidler S; Phillips R; Frater J;
PLoS Pathog; 2016 Jul; 12(7):e1005661. PubMed ID: 27415828
[TBL] [Abstract][Full Text] [Related]
14. Immunological features of coronavirus disease 2019 in patients with cancer.
Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
[TBL] [Abstract][Full Text] [Related]
15. Reappearance of effector T cells is associated with recovery from COVID-19.
Odak I; Barros-Martins J; Bošnjak B; Stahl K; David S; Wiesner O; Busch M; Hoeper MM; Pink I; Welte T; Cornberg M; Stoll M; Goudeva L; Blasczyk R; Ganser A; Prinz I; Förster R; Koenecke C; Schultze-Florey CR
EBioMedicine; 2020 Jul; 57():102885. PubMed ID: 32650275
[TBL] [Abstract][Full Text] [Related]
16. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
17. Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.
Lavon I; Heli C; Brill L; Charbit H; Vaknin-Dembinsky A
Front Immunol; 2019; 10():835. PubMed ID: 31134049
[No Abstract] [Full Text] [Related]
18. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
[TBL] [Abstract][Full Text] [Related]
19. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
Shahbazi M; Moulana Z; Sepidarkish M; Bagherzadeh M; Rezanejad M; Mirzakhani M; Jafari M; Mohammadnia-Afrouzi M
Microb Pathog; 2021 Apr; 153():104779. PubMed ID: 33548481
[TBL] [Abstract][Full Text] [Related]
20. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
Song JW; Zhang C; Fan X; Meng FP; Xu Z; Xia P; Cao WJ; Yang T; Dai XP; Wang SY; Xu RN; Jiang TJ; Li WG; Zhang DW; Zhao P; Shi M; Agrati C; Ippolito G; Maeurer M; Zumla A; Wang FS; Zhang JY
Nat Commun; 2020 Jul; 11(1):3410. PubMed ID: 32641700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]